Effect of Citalopram on Agitation in Alzheimer's Disease – The CitAD Randomized Controlled Trial

IMPORTANCE: Agitation is common, persistent, and associated with adverse consequences for patients with Alzheimer's disease (AD). Pharmacological treatment options, including antipsychotics are not satisfactory. OBJECTIVE: The primary objective was to evaluate the efficacy of citalopram for agi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Porsteinsson, Anton P., Drye, Lea T., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086818/
https://ncbi.nlm.nih.gov/pubmed/24549548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2014.93
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados